Clinical Trial Update: Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta [Phase 1]

View source ↗

Summary

Phase 1 study evaluating romosozumab in children and adolescents with Osteogenesis Imperfecta has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• Romosozumab (romosozumab)

Snippet

Sponsor: Amgen | Conditions: Osteogenesis Imperfecta | Phase 1 | Status: COMPLETED | Results posted: 2024-04-15